Introduction to Sales Manager
Leili has been working in Shengnuo for 12years, she is in charge the sales of peptide API. Assitance of the FDA,COFRIS and KFDA inspection and also the customers’ Audit.
She is familiar with the DMF document and the preparation, attending much of the API exhibition, such as CPHI China, CPHI Japan, CPHI india, CPHI world wide etc. Established the stong connection with the peptide clients.
She is passionate about her work and loves life. She is a very principled gold medal salesman.
The company has participated in the national 11th Five-Year Plan major new drug development project “Key Technological Research on Chemical Modification of Peptides and Industrial Scale Preparation”.
The national technology innovation fund for small and medium-sized enterprises “Nesiritide”, a new anti-heart failure drug, has entered the clinical research stage. In 2010, it was supported by the special funds of the emerging industries of Sichuan Economic Commission and the production of polypeptide drugs. The above projects have completed the project construction content.
It has more than 50 key technologies for the large-scale production of polypeptide drugs and products on the market at home and abroad, with a single batch yield of up to kg level; it has advanced international technologies such as large-scale production of thiocyclic peptide, large-scale production of carbocyclic peptide, complex polypeptide technology, and rapid synthesis of polypeptide technology;
it has applied for 23 patents for invention; it has obtained 5 patents for invention, and relies on its excellent synthesis of polypeptide. And the key technology of modification has become the leader of the domestic polypeptide industry.
The founder of the company, Mr. Wen Yongjun, is the first polypeptide drug on the market in China, Hainan Neutral Thymopentin (and Japan) and the originator of thymopentin alpha 1 with sales revenue of more than 500 million yuan, as well as the leader of the research and development and production team of stable polypeptide drugs.
The company attaches great importance to the combination of learning and research, and has formed a close strategic partnership with scientific research institutes such as Sichuan University, Landa University, Jida University, Military Academy, Chinese Academy of Sciences Organic Institute, Provincial Institute of Pharmaceutical Inspection, etc.
It has successfully realized the industrialization transformation of a number of new polypeptide drugs for Chengdu Austria, Zhejiang Haizheng, Kazakhstan Pharmaceutical and Hainan Neutralization.
The company cooperates closely with foreign pharmaceutical polypeptide industry, cooperates with a polypeptide manufacturing enterprise in India, trains and directs employees of Indian factories, all of which use our own technology;
maintains contacts and exchanges with internationally renowned polypeptide technology research units, and studies the structure and function of biotechnological drugs from various angles and in depth for further application. Accumulate scientific data and lay a solid foundation.
We are looking forward to doing business with you.
Have a good day!